Structure Net Income vs Begin Period Cash Flow Analysis
| GPCR Stock | 31.25 0.46 1.45% |
Structure Therapeutics financial indicator trend analysis is much more than just breaking down Structure Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Structure Therapeutics is a good investment. Please check the relationship between Structure Therapeutics Net Income and its Begin Period Cash Flow accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Structure Therapeutics American. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
Net Income vs Begin Period Cash Flow
Net Income vs Begin Period Cash Flow Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Structure Therapeutics Net Income account and Begin Period Cash Flow. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Structure Therapeutics' Net Income and Begin Period Cash Flow is -0.65. Overlapping area represents the amount of variation of Net Income that can explain the historical movement of Begin Period Cash Flow in the same time period over historical financial statements of Structure Therapeutics American, assuming nothing else is changed. The correlation between historical values of Structure Therapeutics' Net Income and Begin Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income of Structure Therapeutics American are associated (or correlated) with its Begin Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Begin Period Cash Flow has no effect on the direction of Net Income i.e., Structure Therapeutics' Net Income and Begin Period Cash Flow go up and down completely randomly.
Correlation Coefficient | -0.65 |
| Relationship Direction | Negative |
| Relationship Strength | Weak |
Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Structure Therapeutics financial statement analysis. It represents the amount of money remaining after all of Structure Therapeutics American operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most indicators from Structure Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Structure Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Structure Therapeutics American. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. At this time, Structure Therapeutics' Tax Provision is relatively stable compared to the past year. As of 12/13/2024, Selling General Administrative is likely to grow to about 34.3 M, while Enterprise Value Over EBITDA is likely to drop (14.03).
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 122.2K | 1.5M | 13.4M | 14.1M | Depreciation And Amortization | 266.4K | 277K | 316K | 241.8K |
Structure Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Structure Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pair Trading with Structure Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Structure Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Structure Stock
Moving against Structure Stock
| 0.74 | ESPR | Esperion Therapeutics | PairCorr |
| 0.73 | BMY | Bristol Myers Squibb | PairCorr |
| 0.68 | DYAI | Dyadic International | PairCorr |
| 0.62 | GILD | Gilead Sciences Sell-off Trend | PairCorr |
The ability to find closely correlated positions to Structure Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Structure Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Structure Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Structure Therapeutics American to buy it.
The correlation of Structure Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Structure Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Structure Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Structure Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Structure Stock Analysis
When running Structure Therapeutics' price analysis, check to measure Structure Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Structure Therapeutics is operating at the current time. Most of Structure Therapeutics' value examination focuses on studying past and present price action to predict the probability of Structure Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Structure Therapeutics' price. Additionally, you may evaluate how the addition of Structure Therapeutics to your portfolios can decrease your overall portfolio volatility.